Bassel Nazha

17PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersBiologically active moleculesMolecular targetsEthical use of new technologyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 16, 2026
Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617.

|Apr 14, 2026
Phase II Trial of Opaganib Addition in Metastatic Castration-Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide.

Jacqueline T Brown, Bassel Nazha, Anna C Ferreira

|Aug 09, 2025
Optimizing treatment for metastatic castration-resistant prostate cancer: Food and Drug Administration-approved therapies, emerging strategies, and biomarker-driven approaches.

Faisal Saeed, Jacob E Berchuck, Mehmet Asim Bilen

|May 07, 2025
Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations.

Ibrahim Azar, Husain Yar Khan, Sahar F Bannoura

|Dec 20, 2024
Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes.

Katherine B Case, Dylan J Martini, Melad N Dababneh

|Jul 03, 2024
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation.

Dylan J Martini, Katherine B Case, Derrik Gratz

Pageof 3

Frequent Collaborators

4 joint publications

Mehmet Asim Bilen

2 joint publications

Taofeek Kunle Owonikoko

1 joint publications

Jennifer Wilkinson Carlisle

1 joint publications

Suresh S Ramalingam